XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Cash flows from operating activities:      
Net income $ 223,665 $ 261,340 $ 111,850
Income from discontinued operations (23,687) (39,978) (17,036)
Restructuring payments (52,974) (37,454) (62,071)
Adjustments to reconcile net income to net cash provided by operating activities:      
Restructuring charges and asset impairments, net 27,077 56,223 60,295
Goodwill impairment 0 0 148,181
Depreciation and amortization 203,293 179,650 174,065
Pension plan settlement 31,329 0 0
Special pension plan contribution 0 0 (36,731)
Loss on sale of businesses 0 0 5,786
Gain on sale of technology 0 (6,085) 0
Gain on debt forgiveness 0 0 (10,000)
Stock-based compensation 21,042 24,389 14,882
Deferred tax (benefit) provision 56,981 (25,390) 3,467
Changes in operating assets and liabilities, net of acquisitions/divestitures:      
(Increase) decrease in accounts receivable (35,565) (15,923) 27,794
Decrease in finance receivables 79,918 125,991 119,883
Decrease (increase) in inventories 93 7,324 (2,880)
(Increase) decrease in other current assets and prepayments (22,609) 9,118 (717)
Decrease in accounts payable and accrued liabilities (3,180) (13,238) (97,783)
Increase (decrease) in current and non-current income taxes (24,807) (14,581) (1,661)
Decrease in advance billings (21,506) (21,193) (48,432)
Other, net (37,705) (23,384) 14,017
Net cash provided by operating activities: continuing operations 421,365 466,809 402,909
Net cash (used in) provided by operating activities: discontinued operations (29,103) 29,004 93,213
Net cash provided by operating activities 392,262 495,813 496,122
Cash flows from investing activities:      
Purchases of available-for-sale securities (81,527) (125,055) (212,810)
Proceeds from sales/maturities of available-for-sale securities 175,820 113,501 211,696
Net change in short-term and other investments 11,838 (8,285) 75,654
Capital expenditures (191,444) (168,097) (159,232)
Proceeds from sale of assets 0 5,458 17,671
Reserve account deposits 21,008 10,954 (2,183)
Acquisitions, net of cash acquired (10,484) (482,853) (37,842)
Other investing activities (4,250) (5,750) (6,908)
Net cash used in investing activities: continuing operations (79,039) (660,127) (113,954)
Net cash provided by (used in) investing activities: discontinued operations 338,783 (2,893) (1,599)
Net cash provided by (used in) investing activities 259,744 (663,020) (115,553)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt 0 1,436,660 894,744
Principal payments of long-term obligations (570,180) (964,550) (371,007)
Decrease in short-term borrowings 0 0 (90,000)
Dividends paid to stockholders (140,498) (139,490) (140,608)
Dividends paid to noncontrolling interests 0 0 (18,528)
Common stock repurchases 0 0 (197,267)
Redemption of noncontrolling interests 0 0 (300,000)
Other financing activities (55,741) 35,127 (6,863)
Net cash (used in) provided by financing activities (766,419) 367,747 (229,529)
Effect of exchange rate changes on cash and cash equivalents (25,381) 43,959 (26,708)
(Decrease) increase in cash and cash equivalents (139,794) 244,499 124,332
Cash and cash equivalents at beginning of period 1,009,021 764,522 640,190
Cash and cash equivalents at end of period 869,227 1,009,021 764,522
Less cash and cash equivalents of discontinued operations 1,965 0 0
Cash and cash equivalents 867,262 1,009,021 764,522
Cash interest paid 171,120 169,279 150,567
Cash income tax payments, net of refunds $ 25,906 $ 53,247 $ 127,299